Boutique Venture Partners specializes in early-stage investments within the healthcare and life sciences sectors. Their strategy focuses on identifying emerging solutions with significant societal impact, partnering with authentic entrepreneurs, and prioritizing companies that develop novel approaches with strong intellectual property and substantial growth potential.
83% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (50% of deals). Average disclosed round size is $19.8M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ventaris Surgical, Inc. | Series A | $30M | Jan 2026 |
 Smartlens, Inc. | Bridge | $5.2M | Oct 2025 |
 Handl Health | Seed | $2.5M | Apr 2024 |
 FluidAI Medical | Series A | $15M | Oct 2023 |
 Mitra Chem | Series B | $60M | Aug 2023 |
| Smartlens, Inc. | Series A | $6.1M | Jul 2023 |
Top Co-Investors
Graphene Ventures2 shared
Stanford University1 shared
3E Bioventures Capital1 shared
Wilson Sonsini1 shared
Mucker Capital1 shared
Everywhere1 shared
Tau Ventures1 shared
Techstars1 shared
Longitude Capital1 shared
Vensana Capital1 shared
Atypical1 shared
Neotribe1 shared
GM1 shared
Fontinalis Partners1 shared
Earthshot Ventures1 shared
GS Futures1 shared
Zeon Ventures1 shared
WovenEarth Ventures1 shared
SOSV1 shared
Cur8 Capital1 shared
Last updated: 8 March 2026